Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Blood (2024) 143 (25): 2654–2665.

https://doi.org/10.1182/blood.2023023301

Published: 2024

Includes: Supplemental data

Journal Articles

Favorable Fertility Outcome in a Large Cohort of Sickle Cell Disease Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 240.

https://doi.org/10.1182/blood-2023-178128

Published: 2023

Journal Articles

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience

Reem Alasbali, Mohsen Alzahrani, Saud Alhayli, Walid Rasheed, Phavina Akhom, Karina Wilkerson, Mohammed Essa, Riad Elfakih, Bader Alahmari, Hadeel Samarkandi, Syed Osman Ahmed, Ayman Saad, Hazza A. Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Adetola A. Kassim, Ali D Alahmari

Blood (2023) 142 (Supplement 1): 1042.

https://doi.org/10.1182/blood-2023-189914

Published: 2023

Journal Articles

Effect of ABO Mismatch and RBC Alloimmunization on the Outcomes of Patients with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplantation

Blood (2022) 140 (Supplement 1): 7599–7600.

https://doi.org/10.1182/blood-2022-158787

Published: 2022

Journal Articles

Outcome of Advanced Stage Diffuse Large B-Cell Lymphoma; Experience from Saudi Arabia

Ahmed Alaskar, Naila Shaheen, Farhan Khalid, Mohsen Alzahrani, Giamal Edin Gmati, Bader Alahmari, Hind Salama, Bayan Albadah, May Anne Mendoza, Maryam Almotairi, Rania Jaha, Ayman Alhejazi

Blood (2022) 140 (Supplement 1): 11974–11976.

https://doi.org/10.1182/blood-2022-165054

Published: 2022

Journal Articles

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Aamer Aleem, Farjah Alqahtani, Ahmed Jamal, Nora A. Alkhudair, Mashail Alghafis, Hajar Wan Zuki Siti, Bader Alahmari, Hend Salama, Giamal Edin Gmati, Mohsen Alzahrani, Ayman Alhejazi, Naila A. Shaheen, Abdullah M Alrajhi, Mansour Alfayez, Zafar Iqbal, Ahmed Alaskar

Blood (2022) 140 (Supplement 1): 12220–12221.

https://doi.org/10.1182/blood-2022-168926

Published: 2022

Journal Articles

Cluster of Differentiation 20 Expression and Rituximab Use Do Not Improve Outcome of Classical Hodgkin Lymphoma Patients

Khadega A Abuelgasim, Raed Al Shammari, Saeed Alshieban, Bader Alahmari, MD, Mohsen Alzahrani, Ayman Alhejazi, MD, Ahmed Alaskar, Moussab Damlaj

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-135917

Published: 2020

Journal Articles

Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience

Giamal Edin Gmati, MD, Nadine Mabsut, Zainab Matar, Mona Alshami, Husam Shahata, Areej Alkhesaifi, Mohamed Alharbi, Nashmia Almutairi, Ashwaq Alolayan, Mohsen Alzahrani, Abdullah Algarni, Abdulrahman Alhadab, Ayman Hejazi, Bader Alahmari, Abdul-Rahman Jazieh, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-141782

Published: 2020

Journal Articles

Favourable Outcome of Non Myeloablative Allogeneic HSCT in Adult Patients with Severe Sickle Cell Disease: A Single Center Experience of 110 Patients

Mohsen Alzahrani, Bader Alahmari, Ahmed Alaskar, MD FRCPC, Ayman Hejazi, Giamal Edin Gmati, MD, Khadega A. Abuelgasim, Hind Salama, Abdulrahman Raiza, Abdulrahman Alghamdi, Walid Mashaqbeh, Heba Alshobaki, Tahani Alanazy, Maybelle Balili, Muhammad Qureshi, Mazin Ahmed, Husam Mazin Alsadi, MD, Moussab Damlaj

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-139348

Published: 2020

Journal Articles

Clinicopathological Description from the Largest Series of Patients with the Novel Pro106Leu MPL gene Mutation Associated with Hereditary Thrombocythemia

Musa Alzahrani, MBBS, MHSc, Areej Al Mugairi, Saeed Al Turki, Waleed Al Rajban, Fatimah Alshalati, Khadega A. Abuelgasim, Bader Alahmari, Thamer Al Bogami, Osama Ali, MD, Fahad Almodaihsh, Maram Alotaibi, Aamer Aleem, MBBS, FRCP, FRCPath, Ahmed Alaskar, MD FRCPC

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-136077

Published: 2020

Journal Articles

Hematological Profile in the Saudi Population: Reference Intervals By Gender, Age and Regions

Ahmed Alaskar, Hina Rehan, May Anne Mendoza, Aljowhara Alsahan, Anita Immanuel, BSc, Ayman Alhejazi, MD, Khadega Abuelgasim, Hind Salama, Moussab Damlaj, Giamal Gmati, Mohsen Alzahrani, Mushtaq Rather, Bader Alahmari, Areej Al Mugairi, Anwar Ahmed

Blood (2019) 134 (Supplement_1): 5804.

https://doi.org/10.1182/blood-2019-125264

Published: 2019

Journal Articles

Chemotherapy Effect on Fertility in Male Patients with Hodgkin and Non-Hodgkin Lymphoma

Ahmed Alaskar, Naila Shaheen, Saba Alsuhaymi, Nouf Alqahtani, Nouf Bin Muammar, Zaha Jamaan, Noura Alhmanai, Mohsen Alhazmi, Shatry Hind, May Anne Mendoza, Ayman Alhejazi, MD, Khadega Abuelgasim, Giamal Gmati, Moussab Damlaj, Hind Salama, Mohsen Alzahrani, Bader Alahmari, Mahmoud Salam, Abin Thomas

Blood (2019) 134 (Supplement_1): 5865.

https://doi.org/10.1182/blood-2019-126447

Published: 2019

Journal Articles

Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia

Ahmed Alaskar, Mohammed Bosaeed, Hina Rehan, May Anne Mendoza, Bader Alahmari, Adel Othman, Ayman Alhejazi, MD, Khadega Abuelgasim, Moussab Damlaj, Mohsen Alzahrani, Giamal Gmati, Hind Salama, Mostafah Abolfotouh, Naila Shaheen

Blood (2019) 134 (Supplement_1): 5871.

https://doi.org/10.1182/blood-2019-123253

Published: 2019

Journal Articles

Outcome of Age-Adapted Approach to HLA-Identical Related Hematopoietic Stem Cell Transplantation in Severe Sickle Cell Disease: Saudi Experience

Mohsen Alzahrani, Moussab Damlaj, Mohammed Essa, Bader Alahmari, Ahmed Alaskar, Ayman Hejazi, Enas Basher, Rodaina Abujoub, Samer Ghazi, Khadega Abuelgasim, Hind Salama, Giamal Gmati, Abdulrahman Alsultan

Blood (2018) 132 (Supplement 1): 3468.

https://doi.org/10.1182/blood-2018-99-115800

Published: 2018

Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC

Blood (2017) 130 (Supplement 1): 2799.

https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799

Published: 2017

Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD

Blood (2017) 130 (Supplement 1): 5549.

https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549

Published: 2017

Journal Articles

Selective Inhibition of α4β1 Integrin (VLA-4) Mitigates GvHD

Bader Alahmari, MD, Jaebok Choi, PhD, Matthew L Cooper, PhD, Kiran R. Vij, MD, Julie Ritchey, Bing Wang, John F DiPersio, MD PhD

Blood (2016) 128 (22): 3344.

https://doi.org/10.1182/blood.V128.22.3344.3344

Published: 2016

Journal Articles

Pharmacologic Co-Blockade of IFNγR and IL6R Pathways to Prevent and Treat GvHD

Jaebok Choi, PhD, Matthew L Cooper, PhD, Kiran R. Vij, MD, Bing Wang, Julie Ritchey, Bader Alahmari, MD, Matthew Holt, John F DiPersio, MD PhD

Blood (2016) 128 (22): 3353.

https://doi.org/10.1182/blood.V128.22.3353.3353

Published: 2016

Journal Articles

Targeting Alpha 4 Integrin (CD49d) to Reduce GvHD

Bader Alahmari, MBBS, Jaebok Choi, PhD, Matthew L Cooper, PhD, Kiran R. Vij, MD, Julie Ritchey, John F. DiPersio, MD PhD

Blood (2015) 126 (23): 4283.

https://doi.org/10.1182/blood.V126.23.4283.4283

Published: 2015

Journal Articles

Targeting VLA-4 to Reduce GvHD

Jaebok Choi, PhD, Matthew L Cooper, PhD, Bader Alahmari, MD, Julie Ritchey, John F. DiPersio, MD PhD

Blood (2014) 124 (21): 3829.

https://doi.org/10.1182/blood.V124.21.3829.3829

Published: 2014

NARROW

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Favorable Fertility Outcome in a Large Cohort of Sickle Cell Disease Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience

Effect of ABO Mismatch and RBC Alloimmunization on the Outcomes of Patients with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplantation

Outcome of Advanced Stage Diffuse Large B-Cell Lymphoma; Experience from Saudi Arabia

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Cluster of Differentiation 20 Expression and Rituximab Use Do Not Improve Outcome of Classical Hodgkin Lymphoma Patients

Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience

Favourable Outcome of Non Myeloablative Allogeneic HSCT in Adult Patients with Severe Sickle Cell Disease: A Single Center Experience of 110 Patients

Clinicopathological Description from the Largest Series of Patients with the Novel Pro106Leu MPL gene Mutation Associated with Hereditary Thrombocythemia

Hematological Profile in the Saudi Population: Reference Intervals By Gender, Age and Regions

Chemotherapy Effect on Fertility in Male Patients with Hodgkin and Non-Hodgkin Lymphoma

Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia

Outcome of Age-Adapted Approach to HLA-Identical Related Hematopoietic Stem Cell Transplantation in Severe Sickle Cell Disease: Saudi Experience

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Selective Inhibition of α4β1 Integrin (VLA-4) Mitigates GvHD

Pharmacologic Co-Blockade of IFNγR and IL6R Pathways to Prevent and Treat GvHD

Targeting Alpha 4 Integrin (CD49d) to Reduce GvHD

Targeting VLA-4 to Reduce GvHD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only